tiprankstipranks
Trending News
More News >
Humana Inc (DE:HUM)
FRANKFURT:HUM
Germany Market

Humana (HUM) Earnings Dates, Call Summary & Reports

Compare
16 Followers

Earnings Data

Report Date
Apr 29, 2026
Before Open (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
8.42
Last Year’s EPS
9.78
Same Quarter Last Year
Based on 19 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 11, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
The call balances meaningful operational and strategic progress (notably strong membership growth, improved retention, CenterWell tailwinds, EPS outperformance in 2025, and capital efficiency gains) with significant near-term headwinds. The dominant risks are a large ~$3.5 billion STARS headwind, 2026 MA margins slightly below breakeven, and uncertainty from the advance rate notice. Management emphasizes confidence in long-term targets (2028) and has plans to adapt to funding changes, but near-term performance will be constrained by STARS and rate uncertainty.
Company Guidance
Humana guided to full‑year 2026 adjusted EPS of at least $9 (versus $17.14 in 2025), expects individual MA membership to grow ~25% in 2026 after roughly 1,000,000 AEP net adds (~20%), with retention up >500 basis points YoY; management said new members will be enterprise‑accretive in 2026, noting >70% of new sales were switchers, >70% of new sales were on 4+‑star contracts (45% of total members in 4+ stars for ’26) while ~30% of new sales are on <4‑star contracts, ~30% are bounce‑backs, and >75% came from higher‑LTV channels (≈+10 ppt YoY). They flagged a net STARS headwind of ~ $3.5B for 2026 (individual + group), expect individual MA margins to be slightly below breakeven in 2026 but to double year‑over‑year when normalized for STARS (e.g., at a 95% 4+‑star mix), and forecast significant improvement in consolidated operating and admin expense ratios from operating leverage and transformation. Other metrics called out: 2025 insurance benefit ratio 90.4%; premium growth ~40% from 2024–2026 with statutory capital requirements rising <20% (capital actions offset >$3B of capital need); CenterWell/Medicaid in 13 states (DSNP +140k, +18%); debt‑to‑cap largely flat; and the company remains focused on unlocking earnings potential by 2028 and returning to top‑quartile STARS by 2028.
Strong Membership Growth
Grew ~1,000,000 members (≈20%) in AEP; management expects individual Medicare Advantage (MA) membership to grow ≈25% for full-year 2026. New sales composition: >70% switchers (typically better economics), ~30% bounce-back members, and >75% of new sales from higher lifetime value channels (≈10 percentage point improvement YoY).
Improved Retention and Onboarding Metrics
Retention rate improved by over 500 basis points year-over-year. Early onboarding indicators showed reduced complaints to Medicare YoY, improved transactional Net Promoter Score, and higher completion rates for health risk assessments (HRAs) — all positive for STARS and member experience.
Solid 2025 Financial Results and EPS Beat
Reported adjusted EPS of $17.14 for 2025, in line with expectations and above initial guidance (~$16.25). Insurance segment full-year benefit ratio 90.4%, slightly better than guidance.
Capital Efficiency and Funding Position
Premium growth expected ~40% from 2024–2026, while statutory capital requirements projected to rise by <20% due to capital optimization. Management noted capital improvements that offset over $3 billion of capital requirements from '24–'26; debt-to-cap expected to remain largely flat.
Operating Efficiency & Transformation Momentum
Expect significant improvement in consolidated operating cost ratio for 2026 driven by operating leverage from membership/revenue growth, tactical cost-cutting (supplier consolidation, early retirement program), outsourcing and automation. Management expects these transformation benefits to accelerate in 2027–2028.
CenterWell & Medicaid Growth
CenterWell contributions turning positive (CenterWell Pharmacy tailwind vs prior decline). Medicaid footprint expanded to 13 states (including Georgia and Texas planned launches), and management expects continued J-curve progress in Medicaid and CenterWell clinics.
Clear Path to Long-Term Margin Targets
Management reiterates goal to 'unlock earnings potential by 2028' and expects a doubling of individual MA pretax margin in 2026 when normalized for STARS outcomes; anchored planning to 75th percentile STARS for long‑term targets.
Key Leadership and Strategic Moves
Aaron Martin joined as President of Medicare Advantage in January; company pursuing a strategic primary care acquisition and intends to fund select small/mid M&A via noncore asset sales.

Humana (DE:HUM) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DE:HUM Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 29, 2026
2026 (Q1)
8.42 / -
9.778
Feb 11, 2026
2025 (Q4)
-3.38 / -3.34
-1.824-83.33% (-1.52)
Nov 05, 2025
2025 (Q3)
2.47 / 2.74
3.512-22.12% (-0.78)
Jul 30, 2025
2025 (Q2)
5.00 / 5.29
5.877-9.91% (-0.58)
Apr 30, 2025
2025 (Q1)
8.50 / 9.78
6.10560.17% (+3.67)
Feb 11, 2025
2024 (Q4)
-1.88 / -1.82
-0.093-1863.64% (-1.73)
Oct 30, 2024
2024 (Q3)
2.89 / 3.51
6.569-46.53% (-3.06)
Jul 31, 2024
2024 (Q2)
4.95 / 5.88
7.548-22.15% (-1.67)
Apr 24, 2024
2024 (Q1)
5.17 / 6.10
7.92-22.92% (-1.82)
Jan 25, 2024
2023 (Q4)
0.68 / -0.09
1.368-106.79% (-1.46)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

DE:HUM Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 11, 2026
€152.15€147.00-3.38%
Nov 05, 2025
€246.10€229.50-6.75%
Jul 30, 2025
€199.31€201.50+1.10%
Apr 30, 2025
€228.26€225.18-1.35%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Humana Inc (DE:HUM) report earnings?
Humana Inc (DE:HUM) is schdueled to report earning on Apr 29, 2026, Before Open (Confirmed).
    What is Humana Inc (DE:HUM) earnings time?
    Humana Inc (DE:HUM) earnings time is at Apr 29, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Humana Inc stock?
          The P/E ratio of Humana is N/A.
            What is DE:HUM EPS forecast?
            DE:HUM EPS forecast for the fiscal quarter 2026 (Q1) is 8.42.

              Humana (DE:HUM) Earnings News

              Is UnitedHealth Stock (UNH) a Buy Ahead of Q4 Earnings?
              Premium
              Market News
              Is UnitedHealth Stock (UNH) a Buy Ahead of Q4 Earnings?
              21d ago
              CVS Earnings: CVS Health Stock Jumps 10% as Earnings Beat Despite Higher Insurance Payouts
              Premium
              Market News
              CVS Earnings: CVS Health Stock Jumps 10% as Earnings Beat Despite Higher Insurance Payouts
              1y ago
              HUM Earnings: Humana Reports Better-than-Expected Q3 Results, Updates Outlook
              Premium
              Market News
              HUM Earnings: Humana Reports Better-than-Expected Q3 Results, Updates Outlook
              1y ago
              Humana (NYSE:HUM) Nosedives on Q4 Loss, Grim Outlook
              Premium
              Market News
              Humana (NYSE:HUM) Nosedives on Q4 Loss, Grim Outlook
              2y ago